Buys Unites Life Science and Pharma Data Firms

In the US, life sciences consultancy Tegra Analytics has been acquired by healthcare data enablement firm Prominence Advisors.

Tegra was founded in 2002, has offices in Columbia, SC, Philadelphia, and Cincinnati, and offers highly customized analytical solutions for companies in the pharmaceuticals, biotech and medical device sectors. Its expertise covers both commercial and clinical lifecycles and is used for territory alignment, call planning, targeting and segmentation, incentive compensation, forecasting and reporting.

Chicago-based Prominence, which helps clients to modernize, integrate and make use of their data, says the combination gives it immediate access to a robust portfolio of advanced analytics capabilities in the life sciences space, enhancing its ability to serve pharmaceutical, biotech, and commercial organizations through end-to-end data strategy. CEO Bobby Bacci states: 'With Tegra Analytics, we're expanding the reach of our data platform to unify healthcare and life sciences data - helping organizations accelerate discoveries, improve patient outcomes, and reduce costs.'

Tegra CEO Matt Hutcheson notes: 'By combining our strategic consulting expertise with Prominence's robust data assets and technology infrastructure, we're uniquely positioned to help life sciences companies make faster, smarter, and more impactful decisions. We're thrilled about the expanded opportunities this creates for our clients and our team.'

The firms are online at www.prominenceadvisors.com and www.tegraanalytics.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.